AGC Partners Advises Qforma on its Sale to SkilaMederi

Transaction Details

AGC Partners is pleased to announce that its client, Qforma, a leading HCIT company focused on  advanced analytics and pharmaceutical solutions, has agreed to be acquired by SkilaMederi, a BelHealth portfolio company providing analytics, software, and consulting solutions for life sciences companies to improve their go-to-market and in-market brand strategies. Qforma and SkilaMederi will be merged together to create the market leader in pharmaceutical and healthcare analytics. With a team led by Hugh Hoffman, AGC Partners acted as sole financial advisor to Qforma. This marks AGC’s second HCIT deal in 2013, following the sale of Acuo Technologies to Lexmark back in January.


“We are very pleased with Hugh and his team at AGC, who were exemplary every step of the way in finding the best outcome for our shareholders," said Roger Jones, CEO of Qforma. “Hugh’s guidance was invaluable throughout the process, and I hope to be able to work with Hugh and his team again in the future.”